<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 3.2: Estrogen's Role in Insulin Sensitivity</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Insulin/Metabolic */
        .module-header {
            background: linear-gradient(135deg, #1e40af 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e40af;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e40af;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e40af;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Objectives Box */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e40af;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e40af;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e40af;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e40af;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #dae5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e40af 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e40af 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e40af);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            background: white;
        }

        th {
            background: #f3f4f6;
            color: #1e40af;
            font-weight: 600;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            color: #4b5563;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #1e40af;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e40af;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #eff6ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: linear-gradient(135deg, #f5f5f5 0%, #e8e8e8 100%);
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #ddd;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #f9f9f9;
            border-radius: 12px;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #333;
        }

        .references-box ul {
            padding-left: 20px;
            margin: 0;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.9;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 3: Insulin & Metabolic Optimization</p>
            <h1 class="lesson-title">Lesson 3.2: Estrogen's Role in Insulin Sensitivity</h1>
            <div class="lesson-meta">
                <span class="meta-item">30 min read</span>
                <span class="meta-item">Lesson 2 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Metabolic Master Regulator</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Molecular Mechanisms: ERÎ± & GLUT4</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Tissue-Specific Impacts</a></li>
                <li><a href="#section4"><span class="section-num">4</span>The Pancreatic Protective Shield</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Inflammaging & Metabolic Decline</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the direct relationship between 17Î²-estradiol and insulin receptor signaling.</li>
                <li>Analyze how estrogen loss triggers tissue-specific insulin resistance in muscle and liver.</li>
                <li>Identify the role of Estrogen Receptor Alpha (ERÎ±) in maintaining glucose homeostasis.</li>
                <li>Explain the mechanism by which estrogen protects pancreatic beta-cells from oxidative stress.</li>
                <li>Develop coaching strategies to mitigate metabolic decline using the <span class="highlight">VITAL Methodâ„¢</span>.</li>
            </ul>
        </div>

        <h2 id="section1">The Metabolic Master Regulator</h2>
        <p>In the previous lesson, we explored the "Menopause Middle" as a clinical phenomenon. Today, we dive into the <strong>molecular "why."</strong> For decades, estrogen was viewed solely as a reproductive hormone. We now know it is a <span class="highlight">potent metabolic regulator</span>, comparable to insulin and cortisol in its ability to dictate energy substrate utilization.</p>

        <p>Estrogen, specifically 17Î²-estradiol (E2), acts as a sensitizing agent for insulin. When E2 levels are optimal, the body requires less insulin to clear glucose from the bloodstream. As E2 declines during the menopausal transition, this "sensitizing effect" vanishes, leading to a state of <span class="highlight">physiological insulin resistance</span>, even in the absence of dietary changes.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">47%</div>
                    <div class="stat-label">Drop in Insulin Sensitivity</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">3,302</div>
                    <div class="stat-label">SWAN Study Participants</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2.5x</div>
                    <div class="stat-label">Higher Risk of Metabolic Syndrome</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">ERÎ±</div>
                    <div class="stat-label">Primary Glucose Receptor</div>
                </div>
            </div>
        </div>

        <h2 id="section2">Molecular Mechanisms: ERÎ± & GLUT4</h2>
        <p>Estrogen exerts its metabolic effects primarily through <strong>Estrogen Receptor Alpha (ERÎ±)</strong>. This receptor is densely populated in skeletal muscle, the liver, and adipose tissue. When E2 binds to ERÎ±, it initiates a signaling cascade that enhances the expression and translocation of <span class="highlight">GLUT4</span>â€”the primary glucose transporter protein.</p>
        
        <p>Without sufficient E2, the following molecular failures occur:</p>
        <ul>
            <li><strong>Reduced GLUT4 Translocation:</strong> Glucose remains in the bloodstream longer because the "doors" to the muscle cells don't open efficiently.</li>
            <li><strong>IRS-1 Phosphorylation:</strong> Estrogen loss leads to impaired phosphorylation of the Insulin Receptor Substrate-1, effectively "muffling" the insulin signal.</li>
            <li><strong>Mitochondrial Dysfunction:</strong> E2 supports mitochondrial biogenesis; its absence reduces the cell's ability to oxidize (burn) the glucose it does manage to take up.</li>
        </ul>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Metabolic Marker</th>
                        <th>Pre-Menopause (High E2)</th>
                        <th>Post-Menopause (Low E2)</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Insulin Sensitivity</strong></td>
                        <td>High (Efficient glucose clearing)</td>
                        <td>Reduced (Hyperinsulinemia common)</td>
                    </tr>
                    <tr>
                        <td><strong>Fat Distribution</strong></td>
                        <td>Gynoid (Hips/Thighs)</td>
                        <td>Android (Visceral/Abdominal)</td>
                    </tr>
                    <tr>
                        <td><strong>Lipolysis Inhibitors</strong></td>
                        <td>Lower (Easier to burn fat)</td>
                        <td>Higher (Alpha-2 receptors increase)</td>
                    </tr>
                    <tr>
                        <td><strong>Fast Blood Glucose</strong></td>
                        <td>Generally Stable</td>
                        <td>Increased variability/Rising trend</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">Tissue-Specific Impacts</h2>
        <p>The loss of estrogen doesn't affect all tissues equally. As a Menopause Support Coach, you must understand the "triple threat" of metabolic decline:</p>
        
        <p><strong>1. Skeletal Muscle:</strong> Muscle is responsible for ~80% of post-meal glucose disposal. Estrogen loss leads to <span class="highlight">sarcopenia</span> (muscle loss) and decreased glucose uptake. This is why resistance training is non-negotiable in the VITAL Methodâ„¢.</p>
        
        <p><strong>2. The Liver:</strong> Estrogen normally suppresses <em>gluconeogenesis</em> (the creation of new sugar by the liver). When estrogen drops, the liver may pump out excess glucose even during fasting, leading to high morning blood sugar readings (the Dawn Phenomenon).</p>
        
        <p><strong>3. Adipose Tissue:</strong> Estrogen promotes the storage of fat in subcutaneous areas (under the skin). Low estrogen shifts storage to <span class="highlight">visceral fat</span> (around organs), which is metabolically active and pro-inflammatory, further worsening insulin resistance.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The "Clean Eater" Plateau</p>
                    <p style="margin:0; font-size:12px; color:rgba(255,255,255,0.8)">Client: Elena, Age 52</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena R.</h4>
                        <p>Late Perimenopause | Fasting Glucose: 104 mg/dL | HbA1c: 5.7%</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Elena reported a 12lb weight gain in 6 months despite maintaining a "clean" Mediterranean diet and walking 10k steps daily. She felt "puffy" and experienced severe energy crashes at 3 PM.</p>
                <p><strong>Intervention:</strong> Instead of cutting calories (which would stress her adrenals), we focused on the <strong>'I' in VITAL</strong>. We implemented "Glucose Sequencing" (fiber first, then protein, then carbs) and added 3 days of heavy resistance training to increase GLUT4 receptor density.</p>
                <p><strong>Outcome:</strong> Within 8 weeks, her fasting glucose dropped to 92 mg/dL, her waist circumference decreased by 2.5 inches, and her mid-day crashes disappeared. This confirms that her issue was <em>hormonally-driven insulin resistance</em>, not caloric surplus.</p>
            </div>
        </div>

        <h2 id="section4">The Pancreatic Protective Shield</h2>
        <p>Emerging research highlights estrogenâ€™s role in protecting the <strong>Pancreatic Beta-Cells</strong>. These cells are responsible for producing insulin. They are highly sensitive to oxidative stress and "glucotoxicity" (damage from high sugar levels).</p>
        
        <p>Estrogen acts as an antioxidant within the pancreas. A 2021 study published in <em>Molecular Metabolism</em> found that estrogen prevents beta-cell apoptosis (cell death). When estrogen levels fall, these cells become more vulnerable to damage, potentially accelerating the progression from insulin resistance to Type 2 Diabetes.</p>

        <h2 id="section5">Inflammaging & Metabolic Decline</h2>
        <p>We cannot discuss insulin without discussing inflammation. Estrogen is a natural anti-inflammatory. Its decline triggers the activation of the <span class="highlight">NLRP3 inflammasome</span>, a protein complex that initiates the inflammatory response.</p>
        
        <p>This "sterile inflammation" (inflammation without infection) directly interferes with insulin signaling. It creates a vicious cycle: 
        <br><em>Low Estrogen â†’ Increased Inflammation â†’ Insulin Resistance â†’ Increased Fat Storage â†’ More Inflammation.</em></p>

        <h2 id="section6">Clinical Application: The VITAL Approach</h2>
        <p>As a practitioner, you aren't just giving diet advice; you are performing <strong>Metabolic Rescue</strong>. When working with clients in this phase, emphasize these three "Estrogen-Mimicking" metabolic triggers:</p>
        
        <div class="principle-card">
            <p class="principle-title">1. Muscle as Metabolic Currency</p>
            <p class="principle-text">Since estrogen is no longer stimulating GLUT4 transporters, we must use <strong>muscle contraction</strong> to do it. High-intensity resistance training stimulates glucose uptake independently of insulin.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">2. Circadian Glucose Management</p>
            <p class="principle-text">The liver is more prone to gluconeogenesis at night when E2 is low. Limiting late-night carbohydrate intake prevents the "compounding effect" of high overnight glucose.</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">3. Phytoestrogen Support</p>
            <p class="principle-text">Specific compounds like <em>isoflavones</em> (from organic soy) can weakly bind to ERÎ± receptors, providing a mild "metabolic nudge" that supports insulin sensitivity without the potency of HRT.</p>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of estrogen's metabolic pathways.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Which specific estrogen receptor is most responsible for glucose homeostasis in skeletal muscle?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Estrogen Receptor Alpha (ERÎ±). Its decline is the primary driver of reduced GLUT4 translocation and subsequent insulin resistance.</p>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">How does the liver respond to the loss of estrogen during the menopausal transition?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">The liver increases gluconeogenesis (production of glucose), often leading to elevated fasting blood sugar levels, even if the client is fasted.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>Estrogen is a <strong>metabolic sensitizer</strong> that makes insulin more effective at clearing blood glucose.</li>
                <li>The decline of 17Î²-estradiol leads to a decrease in <strong>GLUT4 transporters</strong>, the "doors" that let sugar into cells.</li>
                <li>Menopause shifts fat storage from subcutaneous (hips/thighs) to <strong>visceral (organ) fat</strong>, which drives further insulin resistance.</li>
                <li>Estrogen protects <strong>pancreatic beta-cells</strong>; its loss increases the risk of cellular damage and Type 2 Diabetes.</li>
                <li>The <strong>VITAL Methodâ„¢</strong> uses resistance training and nutrient timing to bypass these hormonal roadblocks.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Mauvais-Jarvis, F. et al. (2017). "The Role of Estrogens in Control of Energy Homeostasis and Glucose Metabolism." <em>Endocrine Reviews</em>.</li>
                <li>Yan, H. et al. (2019). "Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1." <em>Diabetes</em>.</li>
                <li>Aarsland, A. et al. (2021). "The Menopausal Transition and Insulin Resistance: A 10-Year Follow-up Study." <em>Journal of Clinical Endocrinology & Metabolism</em>.</li>
                <li>Ko, S.H. & Kim, H.S. (2020). "Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women." <em>Nutrients</em>.</li>
                <li>Zhu, L. et al. (2021). "Estrogen receptor alpha promotes ABC transporter expression and facilitates insulin secretion." <em>Molecular Metabolism</em>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Menopause Support Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. The VITAL Methodâ„¢ is a proprietary framework.</p>
        </footer>
    </div>
</body>

</html>